Autoimmune Hepatitis Diagnosis and Treatment Market Growth, Innovations and Market Size Forecast 2035
According to market projections, the autoimmune hepatitis diagnosis and treatment sector is expected to grow from USD 14.49 billion in 2026 to USD 20.71 billion by 2035, reflecting a CAGR of 3.3%. The autoimmune hepatitis diagnosis and treatment market focuses on tests and therapies for managing autoimmune hepatitis, a condition where the immune system attacks the liver. It includes diagnostics like blood tests and biopsies, plus treatments such as immunosuppressants and corticosteroids.
Last Updated : 05 August 2026Category: DiagnosticsInsight Code: 5124Format: PDF / PPT / Excel
Regulatory Framework for Leading Countries/Regions
Supply Demand Analysis
Production & Consumption Statistics
Export Import Statistics
Price Trend Analysis
Global Autoimmune Hepatitis Diagnosis and Treatment Market Assessment
Overview
Global Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
Type 1
Type 2
Global Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Blood Tests
Liver Tests
Antibody Tests
Other Blood Tests
Liver Biopsy
Imaging Tests
Ultrasound
CT
MRI
Global Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
Medications
Glucocorticoids
Immunosuppressants
Surgery
Liver Transplant
Other Treatments
Global Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
North America Autoimmune Hepatitis Diagnosis and Treatment Market Assessment
Overview
North America Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
Type 1
Type 2
North America Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Blood Tests
Liver Tests
Antibody Tests
Other Blood Tests
Liver Biopsy
Imaging Tests
Ultrasound
CT
MRI
North America Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
Medications
Glucocorticoids
Immunosuppressants
Surgery
Liver Transplant
Other Treatments
Europe Autoimmune Hepatitis Diagnosis and Treatment Market Assessment
Overview
Europe Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
Type 1
Type 2
Europe Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Blood Tests
Liver Tests
Antibody Tests
Other Blood Tests
Liver Biopsy
Imaging Tests
Ultrasound
CT
MRI
Europe Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
Medications
Glucocorticoids
Immunosuppressants
Surgery
Liver Transplant
Other Treatments
Asia Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Assessment
Overview
Asia Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
Type 1
Type 2
Asia Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Blood Tests
Liver Tests
Antibody Tests
Other Blood Tests
Liver Biopsy
Imaging Tests
Ultrasound
CT
MRI
Asia Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
Medications
Glucocorticoids
Immunosuppressants
Surgery
Liver Transplant
Other Treatments
Latin America Autoimmune Hepatitis Diagnosis and Treatment Market Assessment
Overview
Latin America Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
Type 1
Type 2
Latin America Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Blood Tests
Liver Tests
Antibody Tests
Other Blood Tests
Liver Biopsy
Imaging Tests
Ultrasound
CT
MRI
Latin America Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
Medications
Glucocorticoids
Immunosuppressants
Surgery
Liver Transplant
Other Treatments
Middle East and Africa Autoimmune Hepatitis Diagnosis and Treatment Market Assessment
Overview
Middle East and Africa Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
Type 1
Type 2
Middle East and Africa Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Blood Tests
Liver Tests
Antibody Tests
Other Blood Tests
Liver Biopsy
Imaging Tests
Ultrasound
CT
MRI
Middle East and Africa Autoimmune Hepatitis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
Medications
Glucocorticoids
Immunosuppressants
Surgery
Liver Transplant
Other Treatments
Company Profiles
Abbott
Company Overview
Geographic Footprints
Financial Performance
Product Portfolio
SWOT Analysis
R&D Efforts
Recent Developments & Strategic Collaborations
Product Launch/M&A/Technical Collaboration
Siemens Healthcare Private Limited
Beckman Coulter
Roche Diagnostics
Pfizer Inc
GE Healthcare
Philips Healthcare
Cadila Pharmaceuticals
Bristol Myers Squibb Company
Merck & Co., Inc.
Conclusion & Recommendations
FAQ's
Answer : Autoimmune hepatitis diagnosis and treatment market in 2026 is valued at USD 15.46 billion and is projected to climb to USD 20.71 billion by 2035, with a CAGR of 3.30% over the forecast period.
Answer : Symptoms of autoimmune hepatitis can vary but often include fatigue, abdominal discomfort, joint pain, jaundice (yellowing of the skin and eyes), nausea, vomiting, loss of appetite, and dark urine. Some individuals may also experience itching, an enlarged liver or spleen, and spider-like blood vessels on the skin. Early detection and treatment are crucial to manage symptoms and prevent liver damage.
Answer : National Institute of Health, Centers for Disease Control and Prevention, United Network for Organ Sharing | UNOS, UCSF Health, World Health Organization,
Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information, please read our
Cookie Policy
.
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.
sales@towardshealthcare.com
+1 804-441-9344
Download Sample
USA : +1 8044 419344
sales@towardshealthcare.com